Table 5.
Univariate and Multivariate Regression Analysis for Different Indices Predicting Severity of CAD
| Factor | Significant N (%) (n = 49) |
Insignificant N (%) (n = 20) |
Crude OR (95% CI) |
P-value | Adjusted ORa (95% CI) | P-value |
|---|---|---|---|---|---|---|
| BMI | ||||||
|
03 (06.0%) | 03 (15.0%) | Ref | Ref | ||
|
47 (94.0%) | 17 (85.0%) | 2.76 (0.51–15.0) | 0.239 | 3.55 (0.56–22.5) | 0.178 |
| WC | ||||||
|
12 (24.0%) | 11 (55.0%) | Ref | Ref | ||
|
38 (76.0%) | 09 (45.0%) | 3.87 (1.29–11.6) | 0.015** | 4.28 (1.37–13.4) | 0.012** |
| HC | ||||||
|
19 (38.0%) | 10 (50.0%) | Ref | Ref | ||
|
31 (62.0%) | 10 (50.0%) | 1.63 (0.57–4.64) | 0.359 | 1.70 (0.57–5.03) | 0.336 |
| WHR | ||||||
|
26 (54.2%) | 09 (47.4%) | Ref | Ref | ||
|
22 (45.8%) | 10 (52.6%) | 0.76 (0.26–2.21) | 0.616 | 0.79 (0.27–2.31) | 0.663 |
| WHtR | ||||||
|
15 (31.9%) | 12 (60.0%) | Ref | Ref | ||
|
32 (68.1%) | 08 (40.0%) | 3.20 (1.08–9.47) | 0.036** | 3.30 (1.10–9.89) | 0.033** |
| SCFT | ||||||
|
19 (38.0%) | 09 (45.0%) | Ref | Ref | ||
|
31 (62.0%) | 11 (55.0%) | 1.33 (0.47–3.81) | 0.590 | 0.51 (0.12–2.16) | 0.363 |
| PPFT | ||||||
|
20 (40.0%) | 07 (35.0%) | Ref | Ref | ||
|
30 (60.0%) | 13 (65.0%) | 0.81 (0.27–2.38) | 0.698 | 0.41 (0.09–1.78) | 0.235 |
| PRPFT | ||||||
|
21 (42.0%) | 08 (40.0%) | Ref | Ref | ||
|
29 (58.0%) | 12 (60.0%) | 0.9 (0.3–2.65) | 0.878 | 0.9 (0.3–2.72) | 0.872 |
| VFT | ||||||
|
08 (16.0%) | 08 (40.0%) | Ref | Ref | ||
|
42 (84.0%) | 12 (60.0%) | 3.5 (1.1–11.3) | 0.036** | 3.7 (1.1–12.2) | 0.032** |
| VFT/SCFT | ||||||
|
16 (32.0%) | 08 (40.0%) | Ref | Ref | ||
|
34 (68.0%) | 12 (60.0%) | 1.42 (0.48–4.15) | 0.525 | 1.21 (0.32–4.54) | 0.777 |
| VAT | ||||||
|
08 (16.0%) | 08 (40.0%) | Ref | Ref | ||
|
42 (84.0%) | 12 (60.0%) | 3.5 (1.1–11.3) | 0.036** | 3.7 (1.1–12.5) | 0.034** |
| AFI | ||||||
|
44 (88.0%) | 13 (65.0%) | Ref | Ref | ||
|
06 (12.0%) | 07 (35.0%) | 0.25 (0.07–0.89) | 0.032** | 0.25 (0.07–0.89) | 0.033** |
Notes: aAdjusted for traditional risk factors (age, sex, smoking, diabetes mellitus, hypertension and hyperlipidemia). **Significant at P < 0.05 level (2-tailed).
Abbreviations: BMI, body mass index; WC, waist circumference, HC, hip circumference; WHR, waist to hip ratio; WHtR, waist to height ratio; PRPFT, posterior right perinephric fat thickness; SCFT, subcutaneous fat thickness; PPFT, preperitoneal fat thickness; VFT, visceral fat thickness; VFT/SCFT, visceral fat thickness over subcutaneous fat thickness; VAT, visceral adipose tissue volume; AFI, Abdominal wall fat index.